Clinical Trials Logo

Clinical Trial Summary

In this preliminary study, peripheral blood and carcinoma tissue with pericarcinomatous tissue are taken from the patients with ovarian high grade serous carcinoma at several points: before any treatment, after the debulking surgery, and after all the proposed chemotherapy. The differential expression of the T/B lymphocyte receptors in these samples will be analyzed with the platinum-based treatment and survival outcomes of the patients. The primary objective is the expression rates of T/B lymphocyte receptors in different stages of checking points.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03794115
Study type Observational
Source Peking Union Medical College Hospital
Contact Lei Li, M.D.
Phone +8613911988831
Email lileigh@163.com
Status Recruiting
Phase
Start date January 3, 2019
Completion date January 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03422224 - ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation